Amy R DeFelice, MD

Dr. Quezada is an Assistant Professor of Clinical Medicine in the Division of Pulmonary, Allergy, and Critical Care Medicine. A native of Washington Heights, he received his Sc.B. with Honors in Biology from Brown University in Providence, Rhode Island, and his medical degree from Columbia University College of Physicians and Surgeons. He completed residency training in Internal Medicine, and Fellowship in Pulmonary and Critical Care Medicine, at Columbia University Medical Center, serving as Chief Fellow on his last year of fellowship training. He is board-certified in Internal Medicine and Pulmonary Disease by the American Board of Internal Medicine. Dr. Quezada specializes in providing excellent care of patients suffering from lung disease, including patients with asthma, COPD, and interstitial lung disease. He also has special interest in smoking cessation and interventional bronchoscopy. His research interests include smoking cessation, COPD and asthma, serving as a co-primary investigator in a multicenter NIH-sponsored clinical trial. He has also performed research looking into the relationship between sensitization and exposure to indoor allergens in asthma patients residing in inner city neighborhoods, and the development of tools to help identify patients with early COPD.

Dr. Chabot is a beloved and revered pancreatic cancer surgeon, and founder of the Pancreas Center at Columbia/NewYork-Presbyterian. Established in 2006, the Pancreas Center is one of the largest and most effective clinical cancer programs in the world, as well as a transformative research center where scientific discovery leads to trials of new pancreatic cancer therapies. Under Dr. Chabot’s leadership, the Pancreas Center has grown from an informal collaboration to a comprehensive faculty of clinical specialists and scientific and translational researchers. This team now includes three full-time medical oncologists and numerous specialists who support pancreatic patient needs, as well as 13 different full- and part-time laboratories dedicated to pancreas cancer research—more than at any other academic medical center. Dr. Chabot is the David V. Habif Professor of Surgery, chief of hepato-pancreato-biliary (HPB) surgery, and served as vice president of ColumbiaDoctors for many years. He is known for the close rapport he builds with his patients. A highly-regarded surgeon, he has performed more than 2,500 Whipple procedures—a complex operation to remove pancreatic tumors—and participated in many surgical advances that have steadily improved pancreatic cancer outcomes.Dr. Chabot arrived at Columbia/NewYork-Presbyterian in 1983 as an intern. From intern, resident, and fellow to professor, mentor, and director of the Pancreas Center, he has spent his entire career at Columbia/NewYork-Presbyterian, building an intimate understanding of the culture and practice of medicine and surgery. He sits on the scientific advisory board of LetsWin! Pancreatic Cancer and remains singularly committed to the goal of preventing, treating, and curing pancreatic cancer.

Born to French parents, Vincent Duron moved to New York during his early childhood. He left New York to obtain his undergraduate degree at Stanford University, after which he spent the next few years teaching 4th and 6th grade in Queens and Moscow. He returned to New York to obtain his medical degree at the University of Rochester where he graduated with Distinction in Community Service in 2007. He completed his residency in general surgery in 2012 at Brown University Medical School/Rhode Island Hospital where he received multiple research and teaching awards, including the Gold Foundation Humanism and Excellence in Teaching Award. He then returned to the West Coast to complete a fellowship in pediatric surgical critical care at the Children’s Hospital Los Angeles (2013) and then to Texas to complete a fellowship in pediatric surgery at the University of Texas-Houston Medical School (2015). Throughout his years of training, Dr. Duron performed clinical research leading to the publication of multiple articles in pediatric trauma and global health issues. His interests include general pediatric surgery, in particular neonatal anomalies, minimal access surgery, and the critical care treatment of pediatric surgical and trauma patients, as well as access to surgical care in developing countries. He has been involved in multiple global health projects in Russia, Cameroon, Malawi, Kenya, and most recently is actively developing a trauma registry in Iquitos, Peru. At Columbia/NYP, Dr. Duron serves as Co-Director of Fetal Therapy, Surgical Director of the Pediatric ICU, and Director of Minimally Invasive Surgery. In his clinical work, he places an emphasis on developing protocols and evidence-driven measures to treat our sickest surgical patients. In particular he is interested in the study of fluid resuscitation and respiratory failure in the pediatric surgical and trauma patient.